Latest International Expansion News

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

BP8 has completed its inaugural shipment of Indonesian seaweed biomass to South Korean manufacturer MSC, Ltd., under a new sales cooperation agreement with PT Kebula Raya Bestari. This initial contract signals BP8’s growing footprint in the global seaweed supply chain.

Origin Energy has refined its FY25 earnings forecast, buoyed by strong wholesale performance but tempered by Octopus Energy's UK weather-related losses. Despite setbacks, Octopus continues to expand its retail footprint.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Gentrack reported a solid 9.8% revenue increase to NZ$112 million in HY25, driven by recurring revenue growth and international expansion, while net profit after tax surged 34.7%. The company’s outlook remains optimistic as it targets FY25 revenue above NZ$230 million and deeper market penetration across Asia, Europe, and the Middle East.

Life360’s Q1 2025 results reveal robust revenue growth, expanding profitability, and a bullish outlook for FY 2025, driven by a scalable freemium model and international expansion.